You can copy/paste HTML codes anywhere you like, for example in homepage, or even other sites

XML Lessons Learned from Global Administration of Sinopharm (BBIBP-CorV) Vaccine and Its Efficacy against COVID-19 in Older People
Shyh Poh Teo *
Abstract -   Full Text (PDF)
XML The predominance of Newcastle disease virus genotype VII: genome diversity or poor cross-immunity of non-matched vaccines
Shahla Shahsavandi *, Mohammad Majid Ebrahimi, Majid Tebianain
Abstract -   Full Text (PDF)
XML Roles and Functions of Toll-Like Receptors in Coronavirus Infections: Forthcoming Vaccine and Therapeutic Strategies for Confronting COVID-19
Azadeh Zahmatkesh, Masoumeh Bagheri *
Abstract -   Full Text (PDF)
XML Commentary on Corneal Graft Rejection after COVID-19 Vaccination: Our Experience and Concerns
Radhika Natarajan *, Swetha Ravichandran
Abstract -   Full Text (PDF)
XML Immunoinformatics Approach for Designing an HPV Epitope-Based Vaccine Candidate Harboring Built-in Adjuvants
Maryam Mashhadi Abolghasem Shirazi, Arash Arashkia *, Setareh Haghighat, Farzin Roohvand, Seyed Mehdi Sadat
Abstract -   Full Text (PDF)
XML The Optimization of Faecalibacterium prausnitzii Extracellular Vesicle Concentrations on PPARγ and FIAF Expression in the Caco-2 Cell Culture Model
Seyedeh Marzieh Moosavi, Abbas Akhavan Sepahi, Seyed Fazlollah Mousavi, Farzam Vaziri, Seyed Davar Siadat *
Abstract -   Full Text (PDF)
XML Evaluation of the Effect of HSV-tk/GCV Adenoviral Vector Vaccine Candidate in Inhibiting the Growth of Myeloma Tumors by Inducing Autophagy in BALB/c Mice
shima poorghobadi, Kazem Baesi *, Seyed Mehdi Sadat, Asghar Abdoli, Shiva Irani
Abstract -   Full Text (PDF)
XML An Update on Pathogenesis, Diagnosis and Treatment of COVID-19-Related Cytokine Storm
Mehmet soy *, Pamir ATAGUNDUZ, Gokhan Keser
Abstract -   Full Text (PDF)
Back to Original Issue


© 2025 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.